Topicals, generic [Regulatives / Guidelines]

posted by ioanam – Romania, 2013-04-01 09:51 (3893 d 20:50 ago) – Posting: # 10318
Views: 21,886

Thank you very much for your responses.

I consider that EMA must present a clear guideline for this type of products in order to have the same procedure in all EU countries because in some countries is still possible to obtain MA as a well established use product, while other authorities requires more and more trials. This is not ok.

We are all equal, but some are more equal than others (Sorry for this satirical quote adapted to this situation). :yes:

Wish you a beautiful week,
Ioana

Complete thread:

UA Flag
Activity
 Admin contact
22,811 posts in 4,783 threads, 1,641 registered users;
22 visitors (0 registered, 22 guests [including 13 identified bots]).
Forum time: 05:42 CET (Europe/Vienna)

Every man gets a narrower and narrower field of knowledge
in which he must be an expert in order to compete with other people.
The specialist knows more and more about less and less
and finally knows everything about nothing.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5